| Date | Title | Description |
| 03.09.2026 | ASEAN Rapid Diagnostic Test Market to Reach USD 1.36 Billion by 2030 | The ASEAN Rapid Diagnostic Test Market is valued at an estimated USD 1.08 billion in 2025 and is projected to reach USD 1.36 billion by 2030, registering a CAGR of 4.7% during the forecast period. Market growth is being driven by the rising... |
| 06.08.2026 | Gradientech carries out a rights issue of approximately SEK 55 million | Gradientech carries out a rights issue of approximately SEK 55 million
Thu, Aug 06, 2026 14:29 CET Report this content
The Board of Directors of Gradientech AB (publ) (“Gradientech” or “the Company”) decided on 6 August 2026 to carry out a ... |
| 04.08.2026 | Gradientech appoints Sumi Thaker as Chief Executive Officer to lead its next phase of commercial growth | Gradientech appoints Sumi Thaker as Chief Executive Officer to lead its next phase of commercial growth
Tue, Aug 04, 2026 17:24 CET Report this content
Gradientech, a diagnostics company pioneering ultra-rapid antibiotic susceptibility test... |
| 14.07.2026 | Body Fluid Analysis Market to Reach $3.65 Billion by 2031 | The global body fluid analysis market is projected to grow from USD 2.62 billion in 2026 to USD 3.65 billion by 2031, at a CAGR of 6.9% during the forecast period. Market growth is primarily driven by the increasing global incidence of infe... |
| 09.07.2026 | Global In Vitro Diagnostic (IVD) Products Market Share, Growth Drivers, Trends, Overall Sales and Demand Forecast To 2032 | The Global In Vitro Diagnostic (IVD) Products Market is witnessing remarkable growth as healthcare systems worldwide prioritize early disease detection, personalized treatment, and preventive care. In vitro diagnostic products have become a... |
| 07.07.2026 | Molecular Diagnostics Market to Reach $30.74 Billion by 2030 | The global molecular diagnostics market is estimated at USD 19.48 billion in 2025 and is projected to reach USD 30.74 billion by 2030, growing at a CAGR of 9.6% during the forecast period. Market expansion is driven by increasing investment... |
| 27.03.2026 | Plair raises CHF 1 million to expand real-time microbial detection | RAPID-C+ is already commercially available, and Plair, a Venture Kick alumnus, has raised CHF 1 million from bioMérieux to accelerate its global rollout. The system combines continuous sampling on standard agar media with instant particle c... |
| 27.03.2026 | Plair attracts investment from bioMérieux |
Plair’s flagship innovation, RAPID-C+, is a unique real-time viable particle counter that sets a new industry standard in pharmaceutical environmental monitoring. RAPID-C+ is already commercially available. This partnership reinforces bioM... |
| 16.10.2025 | Global multicenter study: QuickMIC® proven 75% faster in sepsis diagnostics | Global multicenter study: QuickMIC® proven 75% faster in sepsis diagnostics
Thu, Oct 16, 2025 10:26 CET Report this content
The diagnostics company Gradientech today announces a new scientific publication confirming the QuickMIC® system to ... |
| 19.09.2025 | Paris-based Juisci raises €5.5 million to transform how healthcare professionals access scientific knowledge | France’s Juisci, a HealthTech startup that transforms the way healthcare professionals consume scientific knowledge, has secured €5.5 million in Seed funding in order to boost R&D, scale its team, and accelerate international expansion,... |
| 26.06.2025 | Capitainer strengthens board to accelerate global growth | Capitainer strengthens board to accelerate global growth
Thu, Jun 26, 2025 10:50 CET Report this content
Capitainer AB has appointed a new Board of Directors as the company accelerates its international expansion and scales up to meet growi... |
| 22.05.2025 | Bayer, Pfizer, Other Big Global Firms Join Shanghai Open Innovation Initiative | (Yicai) May 22 -- The innovation centers of Germany's Bayer, US' Pfizer, Japan's Sony Group, Denmark's Novo Nordisk, and France's BioMérieux have joined the Group Open Innovation initiative of Pudong District of Shanghai.
The research and d... |
| 07.04.2025 | Elypta Strengthens Commercial Focus, Welcomes Dr. Hilja Ibert to Board of Directors | Elypta Strengthens Commercial Focus, Welcomes Dr. Hilja Ibert to Board of Directors
Mon, Apr 07, 2025 08:30 CET Report this content
Stockholm, Sweden, April 7, 2025. Elypta, the Swedish company pioneering metabolism-based early cancer detec... |
| 07.03.2025 | bioMérieux - 2024 Financial Results | bioMérieux
Full year sales reaching €3,980 million, representing +10.3% organic growth, exceeding the 2024 sales guidance of +8% to +10%
MARCY-L'ÉTOILE, France, March 7, 2025 /PRNewswire-PRWeb/ -- The Board of Directors of bioMérieux, a wor... |
| 19.11.2024 | QVance and bioMérieux: A New Era in Nordic Quality Control for Advanced Therapies | In the fast-paced world of biotechnology, partnerships can be the lifeblood of innovation. On November 18, 2024, QVance AB, a Swedish startup, announced a significant partnership with bioMérieux Sweden AB. This collaboration aims to elevate... |
| 18.11.2024 | QVance Announces Partnership | QVance Announces Partnership
Mon, Nov 18, 2024 08:50 CET Report this content
NextCell Pharma AB* comments on its subsidiary QVance’s partnership with bioMérieux Sweden AB, which aims to strengthen quality control analytics for cell and gene... |
| 18.11.2024 | QVance AB Announces Nordic Partnership with bioMérieux | QVance AB Announces Nordic Partnership with bioMérieux
Mon, Nov 18, 2024 08:45 CET Report this content
QVance AB, Huddinge, Sweden has today announced it has entered into a partnership with bioMérieux Sweden AB, aimed at enhancing the quali... |
| 17.06.2024 | Companion Diagnostics Market Size to Reach $13.74 Billion by 2030: Latest Report by Vantage Market Research | According to a market research study published by Vantage Market Research, the demand analysis of Global Companion Diagnostics Market size revenue was valued at approximately $5.59 Bn in 2022 and is expected to reach around $13.74 Bn by 203... |
| 08.05.2024 | Sanofi, Other French Healthcare, Biotech Firms Hike Investment in Chinese Market | (Yicai) May 8 -- French healthcare firms, including Sanofi, bioMérieux, and the Mérieux Foundation, will continue to increase their investment in China to promote the research and development of innovative first-in-class drugs and the excha... |
| 23.04.2024 | The future of healthcare on display: Day 1 of Medlab West Africa wraps up | The first day of the highly anticipated Medlab West Africa Exhibition and Conference has drawn to a close, leaving attendees and exhibitors alike buzzing with excitement. The venue was a hive of activity, showcasing the latest advancements ... |
| 12.03.2024 | STD Diagnostics Market to Reach USD 16.06 Billion by 2030, Driven by Rising Incidence & Improved Screening Technologies | STD diagnostics Market
STD Diagnostics Market Analysis, Size, Share, Industry Trends and Growth Outlook AUSTIN, TEXAS, UNITED STATES, March 12, 2024 /EINPresswire.com/ -- The global sexually transmitted disease (STD) diagnostics market is p... |
| 11.03.2024 | In Vitro Diagnostics (IVD) Market is Expected to Reach $130.1 Billion by 2030 - Exclusive Report by Meticulous Research® | According to Meticulous Research®, the global in vitro diagnostics market is expected to register a CAGR of 4.6% from 2023 to reach $130.1 billion by 2030. REDDING, UNITED STATES, March 11, 2024 /EINPresswire.com/ -- According to a new mark... |
| 08.03.2024 | Hepatitis Testing/Diagnosis Market is growing at a CAGR of 5% from 2024 to 2030 by Exactitude Consultancy | Hepatitis Testing/Diagnosis Market
The Exactitude Consultancy Hepatitis Testing/Diagnosis Market Report – Size, Trends, and Forecast 2024-2030
The demand for hepatitis testing/diagnosis is increasing due to rising awareness, prevalence of h... |
| 04.03.2024 | Rising Demand and Advancements in Europe IVD Market 2024: Assisted Reproductive Technology for Fertility Solution | Europe In Vitro Diagnostics Market 2024
Demand forin vitro diagnosticsis on therise, owing to surge in prevalence of various chronic diseases which require use of IVD tests for diagnosis
PORTLAND, OREGON, UNITED STATES, March 4, 2024 /EINPr... |
| 11.04.2023 | The value of the entrepreneur mindset in science | This is a guest post by Ben Pascal, the Greater Philadelphia-based cofounder and chief business officer of Invisible Sentinel, which was acquired by bioMérieux in 2019. He is also the global head of bioMérieux's xPRO Program.
The term “entr... |
| 01.03.2023 | Startup Showcase: bioMerieux – Revolutionizing the Diagnosis Industry | For decades, the medical industry has been relying on in vitro diagnostic solutions to diagnose diseases, monitor treatment progress and guide patient care. However, with the rapidly evolving nature of diseases, it is crucial to have access... |
| 08.12.2022 | Cell and Gene Therapies: bioMérieux partners with NecstGen | LEIDEN, SOUTH HOLLAND, THE NETHERLANDS, December 8, 2022 /EINPresswire.com/ -- bioMérieux and NecstGen, collaborate to accelerate the development of Cell and Gene Therapies (CGT) through the provision of ‘state of the art’ and rapid quality... |
| 21.10.2021 | bioMerieux : BioMérieux – Third-Quarter 2021 Business Review | bioMérieux - Third-Quarter 2021 Business Review
Organic growth of 12.1% at constant exchange rates and scope of consolidation over the first nine months of the year:
€2,452 million in sales Up 8.2% as reported
Q3 sales organic growth at... |
| 29.06.2021 | bioMérieux and Specific Diagnostics announce a co-exclusive distribution agreement for the SPECIFIC REVEAL® Rapid AST system in Europe | “Every lab we encounter wants rapid, easy-to-use susceptibility testing at the right price; we couldn’t reach them all without partnering with an organization with the scale and quality of bioMérieux,” said Paul A. Rhodes, Ph.D., CEO of Spe... |
| 24.06.2021 | bioMerieux : BioMérieux launches EPISEQ® SARS-COV-2, a cloud-based software application for the epidemiological surveillance of SARS-CoV-2 variants | bioMérieux launches EPISEQ® SARS-COV-2,
a cloud-based software application for the epidemiological
surveillance of SARS-CoV-2 variants
Marcy l'Étoile, France - June 24th, 2021 - bioMérieux, a world leader in the field of in vitro diagnostic... |
| 23.06.2021 | bioMerieux : Annual Report 2020 | 2020 ANNUAL REPORT
bioMérieux, a family commitment to combat infectious diseases
bioMérieux is first and foremost a human and scientific adventure that began more than 55 years ago.
Our expertise and our commitment to expand the frontiers o... |
| 30.04.2021 | BIOMÉRIEUX
BioMérieux annonce le marquage CE de son nouveau système d'identification par spectrométrie de masse : VITEK® MS PRIME | bioMérieux announces CE-marking of the new MALDI-TOF mass spectrometry identification system: VITEK® MS PRIME
Marcy l'Etoile, France - April 30, 2021 - bioMérieux, a world leader in the field of in vitro diagnostics, has announced the CE-ma... |
| 07.04.2021 | BIOMÉRIEUX
bioMerieux : BioMérieux announces the CE marking of 3 dengue immunoassays on VIDAS® | bioMérieux announces the CE marking of
3 dengue immunoassays on VIDAS®
Marcy l'Etoile, France - April, 7th 2021 -bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE marking of its innovative and fully-automated... |
| 07.04.2021 | bioMerieux : Universal Registration Document 2020 including Annual Financial Report (PDF) | 2020 UNIVERSAL REGISTRATION DOCUMENT
Including the annual financial report
CONTENTS
GROUP PRESENTATION 2 Message from Chairman & CEO 2 A family commitment 4 A global player in the field of in vitro diagnostics 5 bioMérieux fights COVID-1... |
| 09.03.2021 | bioMerieux : The Biotech Digital Campus joins forces with biotechnology schools and training organizations to develop the talents of tomorrow | An unprecedented alliance serving the French bioproductionsector
'Recipient of a Future Investment Program award'
The Biotech Digital Campus is a recipient of the Engineering Action for innovative professional and support training, funded b... |
| 20.01.2021 | In-vitro Diagnostics (IVD) Market to Reach $118.5 Billion by 2027--Exclusive Report Covering Pre and Post COVID-19 Market Analysis and Forecasts by Meticulous Research® | |
| 01.04.2020 | Coronavirus Business Tracker: How The Private Sector Is Fighting The Covid-19 Pandemic | Alain Mérieux, founder of BioMérieux.AFP via Getty Images |
| 05.01.2016 | bioMérieux Acquires Applied Maths | bioMérieux (Paris:BIM), a French provider of vitro diagnostics solutions, acquired Applied Maths, a Sint-Martens-Latem, Belgium-based developer of software solutions for the biosciences, in particular for databasing, analysis and interpreta... |
| 15.11.2012 | Quanterix Secures $18.5M Series C |
LEXINGTON, MA, Quanterix has closed an $18.5 million Series C financing with participation from all existing investors.
>> Click here for more funding data on Quanterix
>> To export Quanterix funding data to PDF and Excel, c... |
| 24.05.2011 | bioMerieux molecular MRSA test gets FDA clearance | “BioMerieux is committed to bringing innovative solutions to the microbiology lab that reduce the time to results so that clinicians can treat patients more rapidly,” CEO Stephane Bancel said in a statement.
With U.S. regulatory clearance o... |
| - | bioMerieux molecular MRSA test gets FDA clearance | Diagnostics company bioMerieux (PARIS:BIM) has received 510(k) clearance from the U.S. Food and Drug Administration for a test to detect and screen for methicillin-resistant staphylococcus, more commonly called MRSA.
BioMerieux said that it... |
